The company is headquartered in Guangzhou, China, at the address below:
21st Floor, Tower A, Guangzhou Life Science Innovation Center,
No. 51, Luoxuan Road, Guangzhou International Biotech Island,
Guangzhou 510005
People’s Republic of China
The company’s ADSs are traded on the Nasdaq Stock Market under the ticker symbol “WRD”.
On 6th Nov 2025, WeRide successfully completed its Dual Primary Listing on the Main Board of the Hong Kong Stock Exchange, stock code: 0800.HK.
The company’s fiscal year ends on December 31.
Documents filed with the SEC or HKEX are available on the SEC Filings and HKEX Filings section of this investor relations website. Investors can also view the documents at WeRide's page on the SEC’s EDGAR site or HKEX news site.
KPMG Huazhen LLP
WeRide’s Investor Relations team can be reached at ir@weride.ai.